MariMed Shares The How Of Its Success In Cannabis
Welcome to our latest TDR Cannabis Exclusive. We’ve been on location with the MariMed team to learn the secrets of their success, stepping into the thought processes of its leadership and getting to know more about their growth and accomplishments throughout the years. This is the second part of our interview with them, so be sure to catch the first part of this interview with their executives here.
Massachusetts based MariMed Inc (OTCMKTS: MRMD) is a premier multi-state operating cannabis company. Their operations are vertically integrated with control over their entire supply chain. Not only do they cultivate, distribute and sell cannabis, they manufacture extracts, oils, and edibles including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, and more. They’re also responsible for a viral, 850 pound marketing initiative that earned their brand global recognition.
In the world of MSOs, they’re a force to be reckoned with, as they now rank in the top 10 in market cap. Their team has achieved several groundbreaking achievements that have propelled MariMed to the forefront of their industry, and they’re sharing their success story.
Tune in to the podcast and get to hear firsthand from MariMed about how they’ve come to this triumph, starting right from their history and the vision of their founder. They’ll explain how they redefined their capabilities and reached this level of unparalleled growth.
How did they not only cope with but also sail blithely through volatile markets? What secrets do they know about revolutionizing marketing and their communication strategies? And how have they managed to attain such an incredible level of brand loyalty? You’ll hear all of their tales of triumph and see the work behind the curtain.
Join us as we dive into their immense potential on becoming the next industry giant in the world of cannabis. You’ll discover why the best is yet to come for this incredible MariMed team.
__________
* In accordance with an executed agreement between The Dales Report and MariMed, The Dales Report is engaged with the aforementioned on a 12-month contract for $7,500 per month, with the purpose of publicly disseminating information pertaining to MariMed via The Dales Report’s media assets, encompassing its website, diverse social media platforms, and YouTube channel. Compensation for The Dales Report services involves the receipt of a predefined monetary consideration, which may, on certain occasions, encompass ordinary shares in instances where monetary compensation was not obtained. In such instances where share compensation was received, The Dales Report hereby asserts the right to engage in the acquisition or disposition of such shares subsequent to the conclusion of the aforementioned contractual period, in compliance with provincial, state, and federal securities regulations. Please refer to the “Disclosures” section below, which is to be interpreted in conjunction with this disclaimer.
